Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
D000614:Aminocaproates / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D000818:Animals; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006417:Hematuria; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D013552:Swine
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents